MedPath

JAMP PYRIDOSTIGMINE BROMIDE

JAMP PYRIDOSTIGMINE BROMIDE

Approved
DIN Number

02508362

Drug Class

Human

Market Date

Mar 7, 2023

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02508362
AIG Number0107514003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07AA02 PYRIDOSTIGMINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
Health Canada Classification

ACTIVE INGREDIENTS (1)

PYRIDOSTIGMINE BROMIDEActive
Strength: 60 MG
Monograph: PYRIDOSTIGMINE BROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.